1. springer.com. (2019). Advances in experimental medicine and biology. Retrieved May 25, 2021, from https://www.springer.com/series/5584
2. Mate, S., Kadioglu, D., Majeed, R. W., Stöhr, M. R., Folz, M., Vormstein, P., Storf, H., Brucker, D. P., Keune, D., Zerbe, N., Hummel, M., Senghas, K., Prokosch, H. U., & Lablans, M. (2017). Proof-of-concept integration of heterogeneous biobank IT infrastructures into a hybrid biobanking network. Studies in Health Technology and Informatics, 243, 100–104.
3. Freedman, L. P., Cockburn, I. M., & Simcoe, T. S. (2015). The economics of reproducibility in preclinical research. PLoS Biology, 13(6), e1002165. https://doi.org/10.1371/journal.pbio.1002165
4. Campbell, L. D., Astrin, J. J., DeSouza, Y., Giri, J., Patel, A. A., Rawley-Payne, M., Rush, A., & Sieffert, N. (2018). The 2018 revision of the ISBER best practices: Summary of changes and the editorial Team’s development process. Biopreservation and Biobanking, 16(1), 3–6. https://doi.org/10.1089/bio.2018.0001
5. Mendy, M., Caboux, E., Lawlor, R. T., Wright, J., & Wild, C. P. (2017). Common minimum technical standards and protocols for biobanks dedicated to cancer research. International Agency for Research on Cancer.